Position in ADCT
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$38,857
+$2,251 QoQ
Shares Held
10,362
-0.1% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
9 quarters on record
Voting authority
Sole 8%
Shared 0%
None 92%
Common Shares in ADCT Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026CWM, LLC holds $40,413,092 across 53 Drug Manufacturers - Specialty & Generic names. ADCT ranks #33 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
126,740 | $16,696,727 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
19,427 | $11,519,822 | |
| 3 | VTRS |
Viatris Inc
|
196,990 | $2,661,334 | |
| 4 | ZTS |
Zoetis Inc.
|
16,699 | $1,973,988 | |
| 5 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
22,913 | $1,103,260 | |
| 6 | IRWD |
Ironwood Pharmaceuticals Inc
|
278,217 | $976,541 | |
| 7 | PBH |
Prestige Consumer Healthcare Inc.
|
9,360 | $554,767 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
15,579 | $469,239 |
All Filings in ADCT
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $38,857 | 10,362 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $36,606 | 10,370 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $40,156 | 10,039 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $26,749 | 9,981 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $18,768 | 13,311 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $39 | 20 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $75 | 24 | Shares | Sole | 2024-10-08 | |
| 2022-03-31 | $13,955 | 950 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $19,190 | 950 | Shares | Sole | 2022-01-31 | |
| No filing history on record for this holder in this stock. | ||||||